Study: “Worrisome” Changes in Cardiovascular Function Immediately after Vaping, Smoking Traditional Cigarettes
AHA 2022: Chronic users of either e-cigarettes or traditional cigarettes had acute changes in cardiovascular function and performed worse on exercise stress testing than never users in new study.
Apixaban May be the Safer DOAC in Afib, Suggests First Large Comparative Analysis
Apixaban was associated with up to a 28% lower risk of GI bleeding vs the 3 other direct oral anticoagulants in the first large-scale comparative analysis.
7 RSV Myths and Facts: Prepare for the New Wave of Misinformation
RSV is back for the 2022-23 respiratory virus season and is unfamiliar to many. Click through this quick collection of myths already in circulation to prepare.
Daily Dose: Efficacy of Maternal RSV Vaccine
Your daily dose of clinical news you may have missed.
Semaglutide 2.4 mg (Wegovy) Yields "Amazing" Weight Loss in Adolescents, Similar to Adult Response
Semaglutide 2.4 mg (Wegovy) weight loss benefits in adolescents mirror those seen in adults, according to phase 3a trial findings presented at ObesityWeek® 2022.
Pharmacologic Interventions for Adults with Obesity: Guideline Topline for Primary Care
The American Gastroenterological Association released its first medical guideline recommending prescription medications for weight loss in adults with obesity. A review, here.
Practice-related Factors in Primary Care May Limit Weight Management Services Offered
ObesityWeek® 2022. Primary care clinicians report providing on average just 70% of a wide range of clinical weight management services, according to a new survey.
Daily Dose: Blood Pressure Control Declined during Early Months of Pandemic
Wearable Device Uptake Low Among Adults with Cardiovascular Disease, Nationally Representative Study Finds
AHA 2022: An estimated 18% of Americans with heart disease reported using wearables, compared with 29% of the total US population.
RSV Older Adult Vaccine Candidate from GSK Wins FDA Priority Review, PDUFA Date Set
The FDA accepted the GSK BLA and granted priority review to what could be the first vaccine approved against RSV in adults aged ≥60 years, according to the company.
Maternal RSV Vaccine Prevents Infection in Infants, Pfizer Announces
Topline phase 3 trial data showed 81.8% efficacy for the maternal vaccine against severe RSV-related illness in infants from birth through first 90 days of life.
Tirzepatide Associated with More Weight Loss than Placebo Regardless of Obesity-related Comorbidities, New Research Finds
ObesityWeek 2022: Regardless of the number of obesity-related comorbidities, tirzepatide was associated with a greater reduction in body weight than placebo.
Early Months of COVID-19 Associated with Worsening BP Outcomes in Adults with Hypertension, New Study Finds
Use of telemedicine and home blood pressure monitoring may mitigate adverse impact on BP control during future large-scale emergencies, noted researchers.
Daily Dose: Black Adults with Afib Less Likely to Receive Oral Anticoagulation at Hospital Discharge
Investigational Glucagon Receptor/GLP-1 Receptor Dual Agonist Bests Semaglutide for Weight Loss in T2D Patients
ObesityWeek® 2022. Coagonism of the glucagon and GLP-1 receptors appears to result in greater weight loss than GLP-1 receptor agonism alone, study suggests.
Low Uptake of Antiobesity Medications Explored in Patient Perception Survey
ObesityWeek® 2022. Low awareness of antiobesity medications and concerns about cost, side effects revealed as barriers to wider uptake in a new study.
Tirzepatide Led to Clinically Meaningful Improvements in Body Composition in Adults with Obesity/Overweight
ObesityWeek 2022: Tirzepatide-induced weight reduction was associated with body composition improvements in adults with obesity/overweight, found analysis of SURMOUNT-1.
Daily Dose: Low-carb Diet May Help Improve Untreated HbA1c
Black Patients with Afib Significantly Less Likely to Receive Oral Anticoagulation at Hospital Discharge
Black patients were also at significantly increased risk of stroke, bleeding, and mortality vs White patients 1 year following discharge.
New AGA Guidelines Recommend Use of Antiobesity Medications for Weight Management
Adults with obesity who have an inadequate response to lifestyle interventions alone should be offered 1 of 4 suggested medications.
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "New AGA Guidelines Recommend Use of Antiobesity Medications for Weight Management")
